Page last updated: 2024-11-02

piracetam and Blepharospasm-Oromandibular Dyskinesia

piracetam has been researched along with Blepharospasm-Oromandibular Dyskinesia in 2 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zesiewicz, TA1
Louis, ED1
Sullivan, KL1
Menkin, M1
Dunne, PB1
Hauser, RA1
Yardimci, N1
Karatas, M1
Kilinc, M1
Benli, S1

Other Studies

2 other studies available for piracetam and Blepharospasm-Oromandibular Dyskinesia

ArticleYear
Substantial improvement in a Meige's syndrome patient with levetiracetam treatment.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:12

    Topics: Anticonvulsants; Female; Humans; Levetiracetam; Meige Syndrome; Middle Aged; Piracetam; Severity of

2004
Levetiracetam in Meige's syndrome.
    Acta neurologica Scandinavica, 2006, Volume: 114, Issue:1

    Topics: Anticonvulsants; Botulinum Toxins, Type A; Brain; Disorders of Excessive Somnolence; Dose-Response R

2006